User: TahirAmin Topic: IP
Category: drugs :: everywhere
Last updated: Aug 19 2017 19:57 IST RSS 2.0
 
1 to 20 of 9,728    
Indian Biosimilars Market Outlook - Increase in Incidence of Diseases Provide Growth Opportunity 19.8.2017 New Kerala: Business India
Mumbai, August 19, 2017 : Global market intelligence firm, Netscribes, Inc. released its latest report on the 'Biosimilars Market in India 2017'. The increasing incidence of cardiac diseases, cancer and diabetes in the country has resulted in a rise in the demand for biosimilars.
Also found in: [+]
Draft pharma policy calls for trade margins cap 18.8.2017 TOI: All Headlines
Draft pharma policy calls for trade margins cap
Also found in: [+]
Suven gets three process patents for neuro-degenerative drug 17.8.2017 Business Standard: Companies & Industry
BS ReporterHyderabad, 17 August: Hyderabad-based bio pharmaceutical company Suven Life Sciences has received process patents for its new chemical entities(NCE) from Europe, Japan and New Zealand. These process patents are for a pipeline of compounds being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with Neurodegenerative disorders such as Alzheimer's, Attention Deficiency Syndrome(ADHD) among other diseases, according to the company."We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,"said Venkat Jasti, CEO of Suven.Suven has 4 clinical stage compounds, one phase 2 undergoing, one phase 2 ready and one phase 1 completed and one phase 1 commenced molecules. In addition to these clinical compounds, the company has nine internally discovered therapeutic drug candidates ...
Also found in: [+]
Suven gets product patents for neuro-degenerative drug 17.8.2017 DNA: Evolutions
Suven Life Sciences has been granted a patent each by Europe, Japan and New Zealand for a drug used in the treatment of neuro-degenerative diseases.
Also found in: [+]
Former V-C of Madras varsity bags Kalam award 16.8.2017 Hindu: Chennai
Extremely happy to receive award named after former President; proud to have pioneered industry-academia tie-up, says Thyagarajan
Also found in: [+]
Company news 14.8.2017 HBL: Markets
Cadila Healthcare on Monday said patent litigation relating to Aptalis’ drug Canasa used for treatment of ulcerative colitis has been settled. As a result of the settlement, the company’s “US subsidi...
Also found in: [+]
Beauty and the regulatory beast 13.8.2017 Hindu: Op-Ed
Data from gene trials should be open to the wider public for greater transparency and abundant caution
Also found in: [+]
JBF Industries hit fresh 52-week low, tanks 45% in 2 weeks 9.8.2017 Business Standard: News Now
The stock tanked 19% to Rs 143 on BSE at intra-day
Also found in: [+]
How Big Pharma is hindering treatment of the opioid addiction epidemic 8.8.2017 News
Percentage of people in US dying of drug overdoses has effectively quadrupled since 1999
Also found in: [+]
Biotech firm's Big Tobacco model to curb nicotine habit 8.8.2017 All International Stories
Investors' hopes are pinned on 22nd Century's technology - unproven so far - becoming widespread
Also found in: [+]
Tiny biotech firm offers Big Tobacco model to curb its nicotine habit 7.8.2017 DNA: Health
Shares in New York-based 22nd Century Group have soared 80 percent to a three-year high since late last month, when the U. S. Food and Drug Administration proposed cutting the nicotine levels in cigarettes so they aren't so addictive.
Also found in: [+]
Take the generic drug, patients are told - unless insurers say no 7.8.2017 Business Standard: Companies & Industry
Pharma firms are cutting deals with insurance comapnies to favour their brand over cheaper generics
Also found in: [+]
Ayurvedic medicines for diabetes, arthritis commercialised: Government 4.8.2017 All News-IANS Stories
Two important drugs -- AYUSH 82 and AYUSH SG -- developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) have been commercialised, a union minister informed Parliament on Friday.
Also found in: [+]
Two important drugs developed by CCRAS have been commercialized recently: Shri Shripad Naik 4.8.2017 New Kerala: India News
New Delhi, Aug 4: The Central Government has set up four Research Councils, namely Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Siddha (CCRS) and Central Council for Research in Homoeopathy (CCRH) which are involved in research activities, inter-alia including development of new Medicines.
Also found in: [+]
Solan-based Shoolini University Files Two Critical Patents 4.8.2017 New Kerala: World News
SOLAN, India, August 4, 2017 : One of the leading centres of research in the country, Shoolini University of Biotechnology and Management Sciences has recently filed two important research patents.
Also found in: [+]
Flickstree: Sourav Ganguly's Flipboard for videos 4.8.2017 Rediff: Business
Flickstree's technology picks free, non-licensed content from sites like YouTube, Vimeo, Daily Motion and TED Talks and feeds the best videos to users.
Also found in: [+]
Arjuna Natural BCM-95 Curcumin Confirmed by FDA 3.8.2017 New Kerala: Kerala News
KERALA, India, August 3, 2017 : Arjuna Naturals Extracts Ltd.'s BCM-95, a high-potency turmeric extract, has been granted a 'No Questions' response letter from the US Food and Drug Administration (FDA). This letter confirms the complete safety of BCM-95 by US authority and helps position the ingredient as an all-natural, clean and trusted brand of the powerful curcumin antioxidant.
Also found in: [+]
Pfizer delays major M&A as it awaits U.S. tax reform clarity 2.8.2017 Sify Finance
By Bill Berkrot and Natalie Grover
Also found in: [+]
Falling Enbrel, Prevnar sales drag Pfizer revenue down 8% to $1.15 bn 1.8.2017 Business Standard: Companies & Industry
Sales of Enbrel, which Pfizer sells outside the United States and Canada, tumbled about 19.5%
Also found in: [+]
Pfizer revenue misses as demand falls for older drugs, Prevnar 1.8.2017 Sify Finance
By Natalie Grover
Also found in: [+]
1 to 20 of 9,728